Kenneth P. H. Pritzker

Fundador en Rna Diagnostics, Inc. .

Health Services

Health Technology

Perfil

Kenneth P.
H.
Pritzker is the founder and director of RNA Diagnostics, Inc. which is founded in 2010.
He also held a director position at CareRx Corp.
in 2009.

Cargos activos de Kenneth P. H. Pritzker

Empresas	Cargo	Inicio
Rna Diagnostics, Inc. Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.	Fundador	01/01/2010

Todos los cargos activos de Kenneth P. H. Pritzker

Antiguos cargos conocidos de Kenneth P. H. Pritzker.

Empresas	Cargo	Fin
CARERX CORPORATION	Director/Miembro de la Junta	25/06/2009

Ver el detalle de la experiencia de Kenneth P. H. Pritzker.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kenneth P. H. Pritzker.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
CARERX CORPORATION	Health Services

Empresas privadas	1
Rna Diagnostics, Inc. Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.	Health Technology